M. Needle

发表

Salvage therapy after postoperative chemotherapy for primary brain tumors in infants and very young children

A. Cnaan, P. Phillips, Huaqing Zhao, 1998, Cancer.

Epidermal growth factor receptor as a therapeutic target in head and neck cancer.

J. F. De Los Santos, K. P. Raisch, J. Bonner, 2002, Seminars in radiation oncology.

Activity of cetuximab in patients with colorectal cancer refractory to both irinotecan and oxaliplatin.

E. Van Cutsem, R. Mayer, H. Lenz, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase I/IIa study of cetuximab with gemcitabine plus carboplatin in patients with chemotherapy-naive advanced non-small-cell lung cancer.

R. Herbst, F. Fossella, G. Blumenschein, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Safety experience with IMC-C225, an anti-epidermal growth factor receptor antibody.

M. Needle, 2002, Seminars in oncology.

Neurologic and other disorders in relatives of pediatric patients with CNS tumors.

J. Biegel, B. Lange, P. Phillips, 1995, Pediatric neurology.

Prognostic signs in the surgical management of plexiform neurofibroma: the Children's Hospital of Philadelphia experience, 1974-1994.

E. Zackai, A. Cnaan, P. Phillips, 1997, The Journal of pediatrics.

Brainstem tumors in patients with neurofibromatosis type 1

E. Zackai, G. Liu, L. Bilaniuk, 1995, Neurology.

The outcome of chemoreduction treatment in patients with Reese-Ellsworth group V retinoblastoma.

C. Shields, J. Shields, J. Cater, 1998, Archives of ophthalmology.

TiNivo: Safety and Efficacy of Tivozanib-Nivolumab Combination Therapy in Patients with Metastatic Renal Cell Carcinoma.

B. Escudier, P. Barthélémy, L. Albiges, 2020, Annals of oncology : official journal of the European Society for Medical Oncology.

Phase II evaluation of interferon α-2a for progressive or recurrent craniopharyngiomas

V. Mathews, D. Heilman, T. Luerssen, 2000 .

Tivozanib versus sorafenib in patients with advanced renal cell carcinoma (TIVO-3): a phase 3, multicentre, randomised, controlled, open-label study.

C. Porta, M. Atkins, B. Rini, 2019, The Lancet. Oncology.

Combined chemoreduction and adjuvant treatment for intraocular retinoblastoma.

C. Shields, J. Shields, P. De Potter, 1997, Ophthalmology.

Late recurrence of a brain tumor.

M. Needle, L. Rorke, P. Winkler, 1997, Medical and pediatric oncology.

Phase II study of daily oral etoposide in children with recurrent brain tumors and other solid tumors.

P. Phillips, J. Goldwein, J. Belasco, 1997, Medical and pediatric oncology.

Treatment of children with newly diagnosed brain stem gliomas with intravenous recombinant β‐interferon and hyperfractionated radiation therapy: A Childrens Cancer Group phase I/II study

R. Zimmerman, L. Rorke, R. Packer, 1996, Cancer.

Neurofibromatosis type 1: brain stem tumours

R. Zimmerman, G. Liu, L. Bilaniuk, 1997, Neuroradiology.

Phase II trial of topotecan administered as 72-hour continuous infusion in children with refractory solid tumors: a collaborative Pediatric Branch, National Cancer Institute, and Children's Cancer Group Study.

P. Adamson, F. Balis, G. Reaman, 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

M. Needle, M. Needle, L. Schwartzfarb, 1974, Journal of clinical pharmacology.

Amifostine for children with medulloblastoma treated with cisplatin‐based chemotherapy

Michael Fisher, H. Shu, P. Adamson, 2004, Pediatric blood & cancer.

Bilateral macular retinoblastoma managed by chemoreduction and chemothermotherapy.

C. Shields, J. Shields, P. De Potter, 1996, Archives of ophthalmology.

Chemoreduction and local ophthalmic therapy for intraocular retinoblastoma.

C. Shields, D. Friedman, J. Shields, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Central nervous system medulloepithelioma: a series of eight cases including two arising in the pons.

L. Rorke, W. S. Millar, P. Phillips, 1996, Journal of neurosurgery.

A randomized comparison of native Escherichia coli asparaginase and polyethylene glycol conjugated asparaginase for treatment of children with newly diagnosed standard-risk acute lymphoblastic leukemia: a Children's Cancer Group study.

J. Neglia, H. Sather, B. Druker, 2002, Blood.

Carboplatin and vincristine chemotherapy for children with newly diagnosed progressive low-grade gliomas.

J. Finlay, G. Reaman, R. Packer, 1997, Journal of neurosurgery.

Phase II trial of cetuximab in patients with refractory colorectal cancer that expresses the epidermal growth factor receptor.

Neal J Meropol, L. Saltz, R. Mayer, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase Ib and Expansion Study of Gemcitabine, Nab-Paclitaxel, and Ficlatuzumab in Patients With Metastatic Pancreatic Cancer

W. Goessling, J. Meyerhardt, A. Rustgi, 2023, The oncologist.

Cetuximab, a monoclonal antibody targeting the epidermal growth factor receptor, in combination with gemcitabine for advanced pancreatic cancer: a multicenter phase II Trial.

R. Wolff, J. Abbruzzese, A. Lobuglio, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Visual impairment associated with mutism after posterior fossa surgery in children.

S. Galetta, A. Duhaime, G. Liu, 1998, Neurosurgery.

Postoperative surveillance imaging in children with cerebellar astrocytomas.

R. Zimmerman, A. Cnaan, L. Sutton, 1996, Journal of neurosurgery.

Adjuvant chemotherapy for the treatment of intracranial ependymoma of childhood

A. Cnaan, J. Garvin, P. Phillips, 1997, Cancer.

Paternal age and sporadic neurofibromatosis 1: A case‐control study and consideration of the methodologic issues

V. Riccardi, G. Bunin, M. Needle, 1997, Genetic epidemiology.

Short stature in children and adults with neurofibromatosis.

R. Vassilopoulou-sellin, M. Klein, M. Needle, 1995, Pediatric nursing.

A phase I study of anti-kinase insert domain-containing receptor antibody, IMC-1C11, in patients with liver metastases from colorectal carcinoma.

T. Ng, M. Carpenter, J. Posey, 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

Congenital anomalies and genetic disorders in families of children with central nervous system tumours.

J. Biegel, B. Lange, P. Phillips, 1995, Journal of medical genetics.

Multicenter phase I/II study of cetuximab with paclitaxel and carboplatin in untreated patients with stage IV non-small-cell lung cancer.

N. Hanna, K. Kelly, P. Bunn, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Surgical removal of a choroid plexus adenoma using the argon beam coagulator: technical case report.

J. Golden, L. Sutton, M. Needle, 1998, Neurosurgery.

Phase II evaluation of interferon-alpha-2a for progressive or recurrent craniopharyngiomas.

V. Mathews, D. Heilman, T. Luerssen, 2000, Journal of neurosurgery.

Treatment of diencephalic syndrome with chemotherapy

A. Gropman, J. Finlay, G. Reaman, 1998, Cancer.

A phase I study of topotecan as a radiosensitizer for brainstem glioma of childhood: first report of the Children's Cancer Group-0952.

M. Mehta, J. Ater, M. Krailo, 2003, Neuro-oncology.

Gangliogliomas involving the optic chiasm

L. Rorke, S. Galetta, A. Duhaime, 1996, Neurology.

Topotecan, as a radiosensitizer, for brainstem glioma (BSG) of childhood: First report of CCG 0952, a phase i study

M. Mehta, R. Mosher, J. Ater, 1998 .

TIVO-3: Final OS analysis of a phase III, randomized, controlled, multicenter, open-label study to compare tivozanib to sorafenib in subjects with metastatic renal cell carcinoma (RCC).

C. Porta, M. Atkins, B. Rini, 2020 .

The presence and intensity of the cetuximab- induced acne-like rash predicts increased survival in studies across multiple malignances

L. Saltz, J. Abbruzzese, M. Kies, 2003 .

Q-TWiST Analysis of Tivozanib Versus Sorafenib in Patients With Advanced Renal Cell Carcinoma in the TIVO-3 Study.

M. Atkins, B. Rini, B. Escudier, 2021, Clinical genitourinary cancer.

Concurrent cetuximab, cisplatin, and concomitant boost radiotherapy for locoregionally advanced, squamous cell head and neck cancer: a pilot phase II study of a new combined-modality paradigm.

Suzanne L Wolden, Eric Lis, J. Shah, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Emergent/urgent therapeutic irradiation in pediatric oncology: patterns of presentation, treatment, and outcome.

H. Bertsch, J. Goldwein, J. Belasco, 1998, Medical and pediatric oncology.

Convection-enhanced delivery of topotecan into diffuse intrinsic brainstem tumors in children.

Peter Canoll, Jeffrey N Bruce, Richard C E Anderson, 2013, Journal of neurosurgery. Pediatrics.

Neuropsychological Profile of Children With Neurofibromatosis, Brain Tamor, or Both

B. Moore, J. Slopis, J. Ater, 1994, Journal of child neurology.

Phase II Trial of Antiepidermal Growth Factor Receptor Antibody C225 in Patients with Advanced Renal Cell Carcinoma

R. Motzer, M. Ginsberg, R. Amato, 2003, Investigational New Drugs.

Final Overall Survival Results from a Phase 3 Study to Compare Tivozanib to Sorafenib as Third- or Fourth-line Therapy in Subjects with Metastatic Renal Cell Carcinoma.

C. Porta, M. Atkins, B. Rini, 2020, European Urology.

Tivo-3: A phase 3, randomized, controlled, multi-center, open-label study to compare tivozanib hydrochloride to sorafenib in subjects with refractory advanced renal cell carcinoma (RCC).

C. Porta, M. Atkins, B. Rini, 2017 .

Tivozanib vs sorafenib targeted therapy for advanced renal cell carcinoma: Final results of a phase III trial (901) and efficacy results of a 2nd line tivozanib extension study (902).

C. Sternberg, P. Tomczak, Thomas E. Hutson, 2015 .

TiNivo: Tivozanib combined with nivolumab results in prolonged progression free survival in patients with metastatic renal cell carcinoma (mRCC): Final results

A. Ravaud, B. Escudier, P. Barthélémy, 2019, Annals of Oncology.

Tivozanib combined with nivolumab: Phase Ib/II study in metastatic renal cell carcinoma (mRCC).

A. Ravaud, B. Escudier, P. Barthélémy, 2018 .

system tumours . in families of children with central nervous Congenital anomalies and genetic disorders

J. Biegel, B. Lange, P. Phillips, 2022 .

Pediatric Oncology: Clinical Practice and Controversies

M. Needle, 1998 .

Optic gliomas in neurofibromatosis type 1: role of visual evoked potentials.

P. Phillips, P. Malloy, M. Needle, 1995, Pediatric Neurology.

Phase II study of lenalidomide in patients (pts) with metastatic renal cell cancer (MRCC).

R. Amato, M. Needle, M. Khan, 2006, Journal of Clinical Oncology.

Pediatric Oncology: Clinical Practice and Controversies

M. Needle, 1998 .

The Multiple Myeloma Research Foundation (MMRF) CoMMpassSM Study: A Longitudinal Study in Newly-Diagnosed Multiple Myeloma Patients to Assess Genomic Profiles, Immunophenotypes and Clinical Outcomes

J. Carpten, S. Jewell, J. Keats, 2012 .